Pascal Deschatelets - Jan 17, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Scientific Officer
Signature
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
Stock symbol
APLS
Transactions as of
Jan 17, 2025
Transactions value $
-$22,469
Form type
4
Date filed
1/21/2025, 04:02 PM
Previous filing
Jan 14, 2025
Next filing
Jan 23, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$22.5K -750 -0.07% $29.96 1.14M Jan 17, 2025 Direct F1
transaction APLS Common Stock Award $0 +15K +1.32% $0.00 1.15M Jan 21, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
F2 This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.